LCM
VERA icon

Legato Capital Management’s Vera Therapeutics VERA Stock Holding History

Legato Capital Management’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$651K Sell
16,193
-8,511
-34% -$367K 0.06% 452
2025
Q4 		$1.25M Buy
+24,704
New +$877K 0.11% 297
2025
Q2 		– Sell
-13,317
Closed -$320K – 630
2025
Q1 		$320K Sell
13,317
-137
-1% -$4.4K 0.04% 479
2024
Q4 		$569K Buy
13,454
+4,831
+56% +$214K 0.07% 423
2024
Q3 		$381K Buy
8,623
+1,072
+14% +$40.7K 0.05% 476
2024
Q2 		$273K Buy
+7,551
New +$300K 0.04% 497

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Legato Capital Management's VERA Position: Q1 2026 in Review

Legato Capital Management reduced its Vera Therapeutics (VERA) stake by 34% in Q1 2026, selling an estimated $367K and leaving 16,193 shares worth $651K. The position accounts for 0.06% of the portfolio, ranked #452.

Legato Capital Management first reported a position in VERA in Q2 2024 and has held it in 6 quarters since. The position peaked at $1.25M in Q4 2025. 229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Legato Capital Management held 16,193 shares of Vera Therapeutics worth $651K as of Q1 2026.
  • Legato Capital Management sold 8,511 Vera Therapeutics shares in Q1 2026, an estimated $367K.
  • Vera Therapeutics made up 0.06% of Legato Capital Management's portfolio in Q1 2026, its #452 holding.
  • Legato Capital Management first reported a position in Vera Therapeutics in Q2 2024 and has held it in 6 quarters since.
  • Legato Capital Management's Vera Therapeutics position peaked at $1.25M in Q4 2025.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.